Literature DB >> 17277159

Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappaB-dependent antiapoptotic gene products: role of IkappaBalpha kinase and TGF-beta-activated kinase-1.

Kwang Seok Ahn1, Gautam Sethi, Bharat B Aggarwal.   

Abstract

Numerous recent reports suggest that statins (hydroxy-3-methylglutaryl-CoA reductase inhibitors) exhibit potential to suppress tumorigenesis through a mechanism that is not fully understood. Therefore, in this article, we investigated the effects of simvastatin on TNF-alpha-induced cell signaling. We found that simvastatin potentiated the apoptosis induced by TNF-alpha as indicated by intracellular esterase activity, caspase activation, TUNEL, and annexin V staining. This effect of simvastatin correlated with down-regulation of various gene products that mediate cell proliferation (cyclin D1 and cyclooxygenase-2), cell survival (Bcl-2, Bcl-x(L), cellular FLIP, inhibitor of apoptosis protein 1, inhibitor of apoptosis protein 2, and survivin), invasion (matrix mellatoproteinase-9 and ICAM-1), and angiogenesis (vascular endothelial growth factor); all known to be regulated by the NF-kappaB. We found that simvastatin inhibited TNF-alpha-induced NF-kappaB activation, and l-mevalonate reversed the suppressive effect, indicating the role of hydroxy-3-methylglutaryl-CoA reductase. Simvastatin suppressed not only the inducible but also the constitutive NF-kappaB activation. Simvastatin inhibited TNF-alpha-induced IkappaBalpha kinase activation, which led to inhibition of IkappaBalpha phosphorylation and degradation, suppression of p65 phosphorylation, and translocation to the nucleus. NF-kappaB-dependent reporter gene expression induced by TNF-alpha, TNFR1, TNFR-associated death domain protein, TNFR-associated factor 2, TGF-beta-activated kinase 1, receptor-interacting protein, NF-kappaB-inducing kinase, and IkappaB kinase beta was abolished by simvastatin. Overall, our results provide novel insight into the role of simvastatin in potentially preventing and treating cancer through modulation of IkappaB kinase and NF-kappaB-regulated gene products.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277159     DOI: 10.4049/jimmunol.178.4.2507

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.

Authors:  Ajaikumar B Kunnumakkara; Bokyung Sung; Jayaraj Ravindran; Parmeswaran Diagaradjane; Amit Deorukhkar; Sanjit Dey; Cemile Koca; Vivek R Yadav; Zhimin Tong; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2010-09-23       Impact factor: 12.701

2.  Simvastatin reduces burn injury-induced splenic apoptosis via downregulation of the TNF-α/NF-κB pathway.

Authors:  Gaofeng Zhao; Yong-Ming Yu; Masao Kaneki; Ali A Bonab; Ronald G Tompkins; Alan J Fischman
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

Review 3.  Cancer and diet: How are they related?

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Afsaneh Lavasanifar; Bharat B Aggarwal
Journal:  Free Radic Res       Date:  2011-06-09

4.  Antagonistic effect of atorvastatin on high fat diet induced survival during acute Chagas disease.

Authors:  Dazhi Zhao; Kezia Lizardo; Min Hui Cui; Kamalakar Ambadipudi; Jose Lora; Linda A Jelicks; Jyothi F Nagajyothi
Journal:  Microbes Infect       Date:  2016-07-12       Impact factor: 2.700

Review 5.  JNK signaling as a target for anticancer therapy.

Authors:  Kamal S Abdelrahman; Heba A Hassan; Salah A Abdel-Aziz; Adel A Marzouk; Atsushi Narumi; Hiroyuki Konno; Mohamed Abdel-Aziz
Journal:  Pharmacol Rep       Date:  2021-03-12       Impact factor: 3.024

6.  Hydrogen gas inhalation protects against liver ischemia/reperfusion injury by activating the NF-κB signaling pathway.

Authors:  Chao-Bin Zhang; Yi-Chen Tang; Xue-Jun Xu; Shi-Xiang Guo; Huai-Zhi Wang
Journal:  Exp Ther Med       Date:  2015-03-26       Impact factor: 2.447

Review 7.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

8.  Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products.

Authors:  Kanjoormana A Manu; Muthu K Shanmugam; Feng Li; Luxi Chen; Kodappully Sivaraman Siveen; Kwang Seok Ahn; Alan Prem Kumar; Gautam Sethi
Journal:  J Mol Med (Berl)       Date:  2014-03       Impact factor: 4.599

9.  Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway.

Authors:  Kwang Seok Ahn; Gautam Sethi; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-10-16       Impact factor: 5.858

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.